BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sillah K, Williams LR, Laasch HU, Saleem A, Watkins G, Pritchard SA, Price PM, West CM, Welch IM. Computed tomography overestimation of esophageal tumor length: Implications for radiotherapy planning. World J Gastrointest Oncol 2010; 2(4): 197-204 [PMID: 21160598 DOI: 10.4251/wjgo.v2.i4.197]
URL: https://www.wjgnet.com/1948-5204/full/v2/i4/197.htm
Number Citing Articles
Mathieu Hatt, Dimitris Visvikis, Olivier Pradier, Catherine Cheze-le Rest. Baseline 18F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancerEuropean Journal of Nuclear Medicine and Molecular Imaging 2011; 38(9): 1595 doi: 10.1007/s00259-011-1834-9
Dong-Liang Hou, Gao-Feng Shi, Xian-Shu Gao, Junichi Asaumi, Xue-Ying Li, Hui Liu, Chen Yao, Joe Y Chang. Improved longitudinal length accuracy of gross tumor volume delineation with diffusion weighted magnetic resonance imaging for esophageal squamous cell carcinomaRadiation Oncology 2013; 8(1) doi: 10.1186/1748-717X-8-169
S Münch, M Oechsner, SE Combs, D Habermehl. DVH- and NTCP-based dosimetric comparison of different longitudinal margins for VMAT-IMRT of esophageal cancerRadiation Oncology 2017; 12(1) doi: 10.1186/s13014-017-0871-3
M.E. Nowee, F.E.M. Voncken, A.N.T.J. Kotte, L. Goense, P.S.N. van Rossum, A.L.H.M.W. van Lier, S.W. Heijmink, B.M.P. Aleman, J. Nijkamp, G.J. Meijer, I.M. Lips. Gross tumour delineation on computed tomography and positron emission tomography-computed tomography in oesophageal cancer: A nationwide studyClinical and Translational Radiation Oncology 2019; 14: 33 doi: 10.1016/j.ctro.2018.10.003
Seyed Kazem Mirinezhad, Amir Ghasemi Jangjoo, Farshad Seyednejad, Ali Reza Naseri, Mohammad Mohammadzadeh, Behnam Nasiri, Amir Taher Eftekharsadat, Sara Farhang, Mohammad Hossein Somi. Impact of Tumor Length on Survival for Patients with Resected Esophageal CancerAsian Pacific Journal of Cancer Prevention 2014; 15(2): 691 doi: 10.7314/APJCP.2014.15.2.691
Szu-Wei Hsu, Jeffrey S. Chang, Wei-Lun Chang, Forn-Chia Lin, Nan-Tsing Chiu. Measuring distance from the incisors to the esophageal cancer by FDG PET/CT: endoscopy as the referenceBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02206-z
Steen Riisgaard de Blanck, Jonas Scherman-Rydhög, Mette Siemsen, Merete Christensen, Lene Baeksgaard, Rasmus Irming Jølck, Lena Specht, Thomas Lars Andresen, Gitte Fredberg Persson. Feasibility of a novel liquid fiducial marker for use in image guided radiotherapy of oesophageal cancerThe British Journal of Radiology 2018; 91(1092): 20180236 doi: 10.1259/bjr.20180236
Hang Li, Tian-wu Chen, Xiao-ming Zhang, Zhen-lin Li, Xiao-li Chen, Hong-jie Tang, Xiao-hua Huang, Nan Chen, Qi Yang, Jiani Hu. Computed Tomography Scan as a Tool to Predict Tumor T Category in Resectable Esophageal Squamous Cell CarcinomaThe Annals of Thoracic Surgery 2013; 95(5): 1749 doi: 10.1016/j.athoracsur.2013.01.052
David Fuster, Maria Mayoral, Domenico Rubello, Estela Pineda, Gloria Fernández-Esparrach, Mario Pagès, Patrick M. Colletti, Francesca Pons. Is There a Role For PET/CT With Esophagogastric Junction Adenocarcinoma?Clinical Nuclear Medicine 2015; 40(3): e201 doi: 10.1097/RLU.0000000000000661
Hang Li, Tian-wu Chen, Zhen-lin Li, Xiao-ming Zhang, Xiao-li Chen, Li-ying Wang, Li Zhou, Rui Li, Chun-ping Li, Xiao-hua Huang. Tumour size of resectable oesophageal squamous cell carcinoma measured with multidetector computed tomography for predicting regional lymph node metastasis and N stageEuropean Radiology 2012; 22(11): 2487 doi: 10.1007/s00330-012-2512-4
P.S.N. van Rossum, A.L.H.M.W. van Lier, I.M. Lips, G.J. Meijer, O. Reerink, M. van Vulpen, M.G.E.H. Lam, R. van Hillegersberg, J.P. Ruurda. Imaging of oesophageal cancer with FDG-PET/CT and MRIClinical Radiology 2015; 70(1): 81 doi: 10.1016/j.crad.2014.07.017
E. Blais, V. Vendrely, P. Sargos, G. Créhange, F. Huguet, P. Maingon, J.-M. Simon, R. Bourdais, M. Ozsahin, J. Bourhis, K. Clément-Colmou, B. Belghith, M.-A. Proudhom Briois, O. Gilliot, J.-P. Dujols, A. Peyras, C. Dupin, F.-G. Riet, C.-H. Canova, A. Huertas, I. Troussier. Chimioradiothérapie des cancers de l’œsophage : revue critique de la littératureCancer/Radiothérapie 2019; 23(1): 62 doi: 10.1016/j.canrad.2018.05.003
Huimin Li, Fengxiang Li, Jianbin Li, Youzhe Zhu, Yingjie Zhang, Yanluan Guo, Min Xu, Qian Shao, Xijun Liu. Comparison of gross target volumes based on four‐dimensional CT, positron emission tomography‐computed tomography, and magnetic resonance imaging in thoracic esophageal cancerCancer Medicine 2020; 9(15): 5353 doi: 10.1002/cam4.3072
Anna Pellat, Anthony Dohan, Philippe Soyer, Julie Veziant, Romain Coriat, Maximilien Barret. The Role of Magnetic Resonance Imaging in the Management of Esophageal CancerCancers 2022; 14(5): 1141 doi: 10.3390/cancers14051141
石峰 张. Progress in the Application of Magnetic Resonance in the Diagnosis and Treatment of Esophageal CancerAdvances in Clinical Medicine 2023; 13(10): 15547 doi: 10.12677/ACM.2023.13102175
Peter S. N. van Rossum, Richard van Hillegersberg, Frederiek M. Lever, Irene M. Lips, Astrid L. H. M. W. van Lier, Gert J. Meijer, Maarten S. van Leeuwen, Marco van Vulpen, Jelle P. Ruurda. Imaging strategies in the management of oesophageal cancer: what’s the role of MRI?European Radiology 2013; 23(7): 1753 doi: 10.1007/s00330-013-2773-6
Yanluan Guo, Jianbin Li, Peng Zhang, Qian Shao, Min Xu, Yankang Li. Comparative evaluation of target volumes defined by deformable and rigid registration of diagnostic PET/CT to planning CT in primary esophageal cancerMedicine 2017; 96(1): e5528 doi: 10.1097/MD.0000000000005528
Zilong Wu, Bentong Yu. Tumor Size as a Critical Prognostic Factor in T1-2 Stage Esophageal CancerGastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/2796943
Barbara Ruaro, Riccardo Pozzan, Paola Confalonieri, Stefano Tavano, Michael Hughes, Marco Matucci Cerinic, Elisa Baratella, Elisabetta Zanatta, Selene Lerda, Pietro Geri, Marco Confalonieri, Francesco Salton. Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?Pharmaceuticals 2022; 15(8): 1033 doi: 10.3390/ph15081033